ARS Pharmaceuticals Inc. (SPRY) Debt to Equity Ratio
ARS Pharmaceuticals Inc. (SPRY) debt-to-equity ratio history and balance sheet leverage. Analyze D/E ratio in Excel with MarketXLS.
Debt to Equity Ratio Data
| Period | Debt/Equity |
|---|---|
| 2021-12-31 | -0.53 |
| 2022-12-31 | 0.03 |
| 2023-12-31 | 0.01 |
| 2024-12-31 | 0.37 |
Get ARS Pharmaceuticals Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Debt_to_Equity_Ratio("SPRY", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | SPRY | $8.19 | +0.49% | 0.79M |
| 3 | ||||
| 4 | ||||
| 5 |